EGFR and adenocarcinoma: Regarding targetable molecular alterations, adenocarcinomas with STAS have been related to wild type epidermal growth factor receptor (EGFR) [12, 25, 26], ALK rearrangement [23, 26] and Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation [20].